[HTML][HTML] Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
Background The COVID-19 pandemic is caused by the betacoronavirus SARS-CoV-2. In
November 2021, the Omicron variant was discovered and immediately classified as a variant of …
November 2021, the Omicron variant was discovered and immediately classified as a variant of …
[PDF][PDF] A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations
…, KDR Roth, P Kuhn, P Riese, D Schäckermann, J Korn… - Cell reports, 2021 - cell.com
The novel betacoronavirus severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2)
causes a form of severe pneumonia disease called coronavirus disease 2019 (COVID-19). …
causes a form of severe pneumonia disease called coronavirus disease 2019 (COVID-19). …
[HTML][HTML] Baculovirus-free insect cell expression system for high yield antibody and antigen production
J Korn, D Schäckermann, T Kirmann, F Bertoglio… - Scientific reports, 2020 - nature.com
Antibodies are essential tools for therapy and diagnostics. Yet, production remains expensive
as it is mostly done in mammalian expression systems. As most therapeutic IgG require …
as it is mostly done in mammalian expression systems. As most therapeutic IgG require …
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients by phage display is binding to the ACE2-RBD interface and is tolerant to most known recently …
…, P Kuhn, P Riese, D Schäckermann, J Korn… - BioRxiv, 2020 - biorxiv.org
The novel betacoranavirus SARS-CoV-2 causes a form of severe pneumonia disease, termed
COVID-19 (coronavirus disease 2019). Recombinant human antibodies are proven potent …
COVID-19 (coronavirus disease 2019). Recombinant human antibodies are proven potent …
Identification of low micromolar SARS-CoV-2 Mpro inhibitors from hits identified by in silico screens (preprint)
…, KDR Roth, P Kuhn, P Riese, D Schäckermann, J Korn… - 2020 - pesquisa.bvsalud.org
Mpro, also known as 3CLpro, is the main protease of the SARS-CoV-2 coronavirus and, as
such, is essential for the viral life cycle. Two studies have each screened and ranked in silico …
such, is essential for the viral life cycle. Two studies have each screened and ranked in silico …
SARS-CoV-2 D614 and G614 spike variants impair neuronal synapses and exhibit differential fusion ability (preprint)
…, KDR Roth, P Kuhn, P Riese, D Schäckermann, J Korn… - 2020 - pesquisa.bvsalud.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes Coronavirus
disease 2019 (COVID-19) exhibits two major variants based on mutations of its spike protein, …
disease 2019 (COVID-19) exhibits two major variants based on mutations of its spike protein, …
[HTML][HTML] Optimization of canine interleukin-12 production using a baculovirus insect cell expression system
CGM de Pinheiro, MO Pedrosa, NC Teixeira… - BMC Research …, 2016 - Springer
Background Interleukin-12 is an important cytokine in mediating cellular immune responses.
Results Recombinant single-chain canine IL-12 was produced in a baculovirus-insect cell …
Results Recombinant single-chain canine IL-12 was produced in a baculovirus-insect cell …
Distribution and complementarity of hydropathy in mutisunit proteins
AP Korn, RM Burnett - Proteins: structure, function, and …, 1991 - Wiley Online Library
… Contact interfaces have also been investigated by Argos4 and Janin et aL5 Argos found,
in agreement with our observations, that the hydropathy of the average interface lies between …
in agreement with our observations, that the hydropathy of the average interface lies between …
Th17/Treg ratio in human graft-versus-host disease
P Ratajczak, A Janin… - Blood, The Journal …, 2010 - ashpublications.org
Th17 cells have never been explored in human graft-versus-host disease (GVHD). We studied
the correlation between the presence of Th17 cells with histologic and clinical parameters…
the correlation between the presence of Th17 cells with histologic and clinical parameters…
[HTML][HTML] Targeting cancer stem cells to overcome chemoresistance
…, H Lu, M Di Benedetto, G Bousquet, A Janin - International journal of …, 2018 - mdpi.com
Cancers are heterogeneous at the cell level, and the mechanisms leading to cancer heterogeneity
could be clonal evolution or cancer stem cells. Cancer stem cells are resistant to most …
could be clonal evolution or cancer stem cells. Cancer stem cells are resistant to most …